Navigation Links
Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru

Dr Reddy's Laboratories Thursday announced it had entered a co-development and commercialisation agreement with Denmark-based Rheoscience A/S for the joint development of a drug to treat diabetes. //

Under the pact, Rheoscience will fund all costs associated with the Phase-III clinical trials of balaglitazone (DRF 2593), a partial PPAR-gamma agonist, for the treatment of type 2 diabetes.

Dr Reddy's will pay Rheoscience a pre-determined amount towards its share of development costs. According to a statement from Dr Reddy's, Rheoscience will retain marketing rights for the European Union and China while Dr Reddy's will retain marketing rights for the US and the rest of the world.

"We are excited about our first co-development deal for the joint development and commercialisation of balaglitazone. This deal provides Dr Reddy's with an opportunity to commercialise NCEs in key markets thereby transforming Dr Reddy's into an innovation driven business," said G.V. Prasad, CEO of Dr Reddy's Laboratories.

"This deal together with the announcement of Perlecan (Wednesday) reflects our commitment to accelerate the discovery efforts as well as clinical development programmes toward realising our vision of becoming a discovery-led global pharmaceutical company," he said.

The deal with Rheoscience came a day after Dr Reddy's announced the formation of India's first integrated drug development company - Perlecan Pharma Private Limited - with equity capital commitment of $52.5 million from India's leading venture capital investors, Citigroup Venture Capital International Growth Partnership Mauritius Limited and ICICI Venture Funds Management Company and Dr Reddy's.

Perlecan Pharma will be engaged in clinical development and out-licensing of new chemical entity (NCE) assets. Its early priorities will be to advance the clinical development of NCE assets received from Dr Reddy's and thereafter seek out-licensing , co-development or joint commercialisation opportunities.


Related medicine news :

1. Dr Reddy’s Laboratories to challenge patents on drug
2. Dr Reddy’s Laboratories launches Hyalosy
3. Polio Strikes Again
4. Chikungunya Strikes Chennai, India
5. New Research Suggests That Obesity Strikes Faster Growing Kids
6. Research for Back Pain Relief Strikes Gold
7. Polio Strikes Again in Delhi
8. Government Strikes Right Balance with PBS Reform
9. Stroke Due to Inherited Reasons Strikes Women More
10. Super Bug Strikes Again, Many Deaths Reported
11. Carriers With Alzheimers High Risk Gene Type Age Normally Until the Disease Strikes
Post Your Comments:

(Date:11/30/2015)... ... November 30, 2015 , ... ... annual fundraising campaign to raise funds for its research, education, support, and advocacy ... the organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also goes ...
(Date:11/30/2015)... ... ... running, and walking are regular Sunday activities for many South Floridians, but their physical ... That’s when the 7th annual ANF Group Tour de Broward will take place at ... Joe DiMaggio Children’s Hospital. , The community fundraiser, sponsored by ANF Group, consists ...
(Date:11/30/2015)... ... November 30, 2015 , ... ChiliPad , ... to maximize recovery through quality sleep. Tim DiFrancesco, training coach for the LA ... night’s sleep. ChiliPad precisely regulates the surface temperature of each side of the ...
(Date:11/30/2015)... ... 2015 , ... Newly reviewed and approved “NJ Top Dentist”, ... He has both advanced training and considerable experience in reconstructive dentistry with attention ... cosmetic dentistry. He is an active Spear Education member providing full mouth ...
(Date:11/30/2015)... ... , ... Two years ago, Debbie Gregory, the CEO of, found herself ... Meditation (TM). After encouraging a number of veterans to go through the program, ... the talk. , TM is becoming one of the best alternative treatments for Post-Traumatic ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BOCA RATON, Fla. , Nov. 30, ... of Public Research (the Institute) announced today that ... , a medical device start-up company with technology developed ... creation based on publicly-funded research, and bridges early funding ... -based universities and research institutions. ...
(Date:11/30/2015)... Nov. 30, 2015 Baxalta Incorporated ... leader dedicated to delivering transformative therapies to ... conditions, today announced the launch and first ... an extended circulating half-life recombinant factor VIII ... full-length ADVATE [Antihemophilic Factor (Recombinant)]. The treatment ...
(Date:11/30/2015)... Months Ended 30 September 2015 2014RestatedChange%Turnover 545,575 , 518,852 , ... 384,242 , 9.8 Hospital Management Service Income ... (18.3) Medical Insurance Administration Service Income , 2,780 ... and Accessories Sales , 89,645 , 94,580 ... 2,822 , 2,917 , (3.3) Gross ...
Breaking Medicine Technology: